was read the article
array:23 [ "pii" => "S036505962300257X" "issn" => "03650596" "doi" => "10.1016/j.abd.2023.05.007" "estado" => "S300" "fechaPublicacion" => "2024-03-01" "aid" => "874" "copyright" => "Sociedade Brasileira de Dermatologia" "copyrightAnyo" => "2023" "documento" => "article" "crossmark" => 1 "subdocumento" => "crp" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "pt" => array:18 [ "pii" => "S266627522300303X" "issn" => "26662752" "doi" => "10.1016/j.abdp.2023.12.006" "estado" => "S300" "fechaPublicacion" => "2024-03-01" "aid" => "874" "copyright" => "Sociedade Brasileira de Dermatologia" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "pt" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Cartas ‐ Terapia</span>" "titulo" => "Tratamento da psoríase eritrodérmica com guselcumabe: relato de dois casos e revisão da literatura" "tienePdf" => "pt" "tieneTextoCompleto" => "pt" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "319" "paginaFinal" => "320" ] ] "contieneTextoCompleto" => array:1 [ "pt" => true ] "contienePdf" => array:1 [ "pt" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 934 "Ancho" => 2508 "Tamanyo" => 204427 ] ] "descripcion" => array:1 [ "pt" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(A) Psoríase eritrodérmica. (B) Remissão após terapia com guselcumabe.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Esperanza Welsh, Jesus Alberto Cardenas‐de la Garza, Jose Alberto Garcia‐Lozano, Diana Paola Flores‐Gutierrez" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Esperanza" "apellidos" => "Welsh" ] 1 => array:2 [ "nombre" => "Jesus Alberto" "apellidos" => "Cardenas‐de la Garza" ] 2 => array:2 [ "nombre" => "Jose Alberto" "apellidos" => "Garcia‐Lozano" ] 3 => array:2 [ "nombre" => "Diana Paola" "apellidos" => "Flores‐Gutierrez" ] ] ] ] ] "idiomaDefecto" => "pt" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S036505962300257X" "doi" => "10.1016/j.abd.2023.05.007" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S036505962300257X?idApp=UINPBA00008Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S266627522300303X?idApp=UINPBA00008Z" "url" => "/26662752/0000009900000002/v2_202407310539/S266627522300303X/v2_202407310539/pt/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S0365059623002416" "issn" => "03650596" "doi" => "10.1016/j.abd.2023.03.009" "estado" => "S300" "fechaPublicacion" => "2024-03-01" "aid" => "860" "copyright" => "Sociedade Brasileira de Dermatologia" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter - Therapy</span>" "titulo" => "Topical aluminum chloride as a treatment option for Hailey-Hailey disease: a remarkable therapeutic outcome case report" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "321" "paginaFinal" => "323" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 2087 "Ancho" => 2508 "Tamanyo" => 599629 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Left axilla before (A) and after (B) eight weeks of treatment. Decrease in ulcerous-crusted plaques and blisters, and predominance of residual hyperchromia at the end of treatment.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Maraya de Jesus Semblano Bittencourt, Pedro Carneiro Marinho, Thereza Christina Frade, Gabriela Athayde Amin, Lorena Silva de Carvalho, Lívia Eloi Castro Santos" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Maraya de Jesus Semblano" "apellidos" => "Bittencourt" ] 1 => array:2 [ "nombre" => "Pedro Carneiro" "apellidos" => "Marinho" ] 2 => array:2 [ "nombre" => "Thereza Christina" "apellidos" => "Frade" ] 3 => array:2 [ "nombre" => "Gabriela Athayde" "apellidos" => "Amin" ] 4 => array:2 [ "nombre" => "Lorena Silva" "apellidos" => "de Carvalho" ] 5 => array:2 [ "nombre" => "Lívia Eloi Castro" "apellidos" => "Santos" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "pt" => array:9 [ "pii" => "S2666275223002898" "doi" => "10.1016/j.abdp.2023.11.011" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "pt" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275223002898?idApp=UINPBA00008Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059623002416?idApp=UINPBA00008Z" "url" => "/03650596/0000009900000002/v2_202407221312/S0365059623002416/v2_202407221312/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S036505962300243X" "issn" => "03650596" "doi" => "10.1016/j.abd.2023.04.005" "estado" => "S300" "fechaPublicacion" => "2024-03-01" "aid" => "862" "copyright" => "Sociedade Brasileira de Dermatologia" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter - Tropical/Infectious and parasitic dermatology</span>" "titulo" => "Extensive micropustular <span class="elsevierStyleItalic">Tinea capitis</span> in an adult caused by <span class="elsevierStyleItalic">Trichophyton verrucosum</span> with evolution to Kerion Celsi" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "315" "paginaFinal" => "318" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1041 "Ancho" => 3341 "Tamanyo" => 342342 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">(A) Direct mycological examination with hyphae. (B) Culture examination with ocher-colored colonies. (C) Microscopic aspect of the culture with hyphae and rounded chlamydoconidia in strings (arrows).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Hiram Larangeira de Almeida Jr., Luiz Roberto Kramer Costa, Augusto Scott da Rocha" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Hiram" "apellidos" => "Larangeira de Almeida Jr." ] 1 => array:2 [ "nombre" => "Luiz Roberto" "apellidos" => "Kramer Costa" ] 2 => array:2 [ "nombre" => "Augusto" "apellidos" => "Scott da Rocha" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "pt" => array:9 [ "pii" => "S2666275223002916" "doi" => "10.1016/j.abdp.2023.11.013" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "pt" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275223002916?idApp=UINPBA00008Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S036505962300243X?idApp=UINPBA00008Z" "url" => "/03650596/0000009900000002/v2_202407221312/S036505962300243X/v2_202407221312/en/main.assets" ] "en" => array:18 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter - Therapy</span>" "titulo" => "Erythrodermic psoriasis treatment with Guselkumab: report of two cases and literature review" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "319" "paginaFinal" => "320" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Esperanza Welsh, Jesus Alberto Cardenas-de la Garza, José Alberto García-Lozano, Diana Paola Flores-Gutierrez" "autores" => array:4 [ 0 => array:3 [ "nombre" => "Esperanza" "apellidos" => "Welsh" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 1 => array:4 [ "nombre" => "Jesus Alberto" "apellidos" => "Cardenas-de la Garza" "email" => array:1 [ 0 => "cardenasdelagarza@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 2 => array:3 [ "nombre" => "José Alberto" "apellidos" => "García-Lozano" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "Diana Paola" "apellidos" => "Flores-Gutierrez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Welsh Dermatology and Associates, Monterrey Nuevo Leon, Mexico" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Rheumatology Departament, Universidad Autónoma de Nuevo León, Hospital Universitario ‘Dr José Eleuterio González’, Monterrey NL, México" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Department of Clinical Introduction, Faculty of Medicine and University Hospital “Dr. José E. González”, Autonomous Universitiy of Nuevo León, Monterrey, Nuevo León, Mexico" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 934 "Ancho" => 2508 "Tamanyo" => 204427 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0060" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(A) Erythrodermic psoriasis; (B) Remission after guselkumab therapy.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Erythrodermic psoriasis (EP) is an uncommon and possibly fatal psoriasis presentation involving more than 80% of the body surface area (BSA).<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Controlled clinical trials and current treatment choices for EP are limited and, compared to plaque-type psoriasis, EP patients seem to have a worse clinical response to standard therapies.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Guselkumab is a human monoclonal antibody against Interleukin-23 (IL-23), that joins the p19 subunit of IL-23 and has exhibited excellent and sustained treatment effects in moderate-to-severe plaque-type psoriasis.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> However, reports of guselkumab efficacy in EP are scarce. This study aims to report two cases of EP treated with guselkumab with sustained efficacy and perform a literature review of guselkumab in the treatment of EP.</p><p id="par0010" class="elsevierStylePara elsevierViewall">We present a 65-year-old woman with a 4-year history of psoriasis previously treated with topical steroids. Her disease flared involving >90% of her BSA. Skin examination demonstrated symmetrical erythematous scaly plaques (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>A). A punch biopsy was compatible with psoriasis. Guselkumab (100 mg via subcutaneous injection at week 0 and week 4, followed by a dose every 8 weeks), topical steroids, and emollients were started. The patient achieved a complete response (PASI100) by week 12 (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>B) and has maintained it for over 32 months. The second case is a 51-year-old man with a 1-year history of plaque-type psoriasis treated with topical steroids. He presented with erythematous plaques on his extremities and trunk that spread to a PASI 40. Histopathological analysis was compatible with psoriasis. Treatment with guselkumab as mentioned previously resulted in complete resolution by week 12 which has persisted for 2-years.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">We performed a literature review of EP treated with guselkumab on August 15, 2022, through MEDLINE (PubMed) with keywords erythroderm* AND guselkumab. Of the 10 results, we excluded 3 as they were about other conditions (non-erythrodermic psoriasis, pustulotic arthro-osteitis, palmoplantar pustulosis, palmoplantar psoriasis, psoriatic arthritis, erythrodermic ichthyosis) and 3 that were reviews.</p><p id="par0020" class="elsevierStylePara elsevierViewall">We included 4 articles with 26 patients combined with EP in treatment with guselkumab. Most patients were men (n = 24), and the mean age was 49.9 years.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1–4</span></a> All patients showed a good response during treatment, except one with concomitant Castleman’s disease and one that withdrew consent from the study.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1–4</span></a> Sano et al.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> reported 10 (90.9%) patients with “treatment success” at week 16. Ten (90.9%) patients reported a mean PASI of 3.9 (SD = 4.27) with a median improvement of 94.1% by week 52. Chiang et al.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> reported 13 patients in follow-up for 28 weeks, where 8 (61.5%) reached PASI 50 response by week 12. Megna et al.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> reported one patient with PASI 100 at 20 weeks and sustained effect by week 48. Zanelli et al.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> reported a patient with multicentric Castleman’s disease and EP that did not respond to guselkumab therapy.</p><p id="par0025" class="elsevierStylePara elsevierViewall">The two patients reported herein had a PASI 100 response by week 12 with sustained effect at the last follow-up at 24 and 32 months and no adverse events. IL-23 inhibitors have shown higher PASI90 and PASI100 response rates compared to anti-TNF alpha inhibitors in moderate and severe psoriasis with a similar adverse event profile.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> Our review found few cases and case series of EP treated with guselkumab but a high response rate. Reported adverse events were infrequent and mild. Several factors influence treatment decisions, including infections (e.g., tuberculosis or hepatitis B/C), affordability, comorbidities, and accessibility. Our study suggests that guselkumab is an efficient treatment for EP, given the results, safety, and long-term effectiveness it has shown. Comparative studies, that include other biologics like risankizumab and tildrakizumab, are needed to define the best treatment for patients with EP.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Financial support</span><p id="par0030" class="elsevierStylePara elsevierViewall">None declared.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Authors’ contributions</span><p id="par0035" class="elsevierStylePara elsevierViewall">Esperanza Welsh: Collected the clinical data and reviewed the draft of the manuscript. Approval of the final version of the manuscript.</p><p id="par0040" class="elsevierStylePara elsevierViewall">Jesus Alberto Cardenas-de la Garza: Collected the clinical data, adapted the clinical image, and wrote a draft of the manuscript. Approval of the final version of the manuscript.</p><p id="par0045" class="elsevierStylePara elsevierViewall">José Alberto García-Lozano: Collected the clinical data and obtained the figure. Approval of the final version of the manuscript.</p><p id="par0050" class="elsevierStylePara elsevierViewall">Diana Paola Flores-Gutierrez: Collected the clinical data and wrote a draft of the manuscript. Approval of the final version of the manuscript.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Conflicts of interest</span><p id="par0055" class="elsevierStylePara elsevierViewall">Esperanza Welsh has been a consultant and/or speaker for Merz, Leo Pharma, and Janssen.</p><p id="par0060" class="elsevierStylePara elsevierViewall">Jesus Alberto Cardenas-de la Garza has been a consultant for Leo Pharma.</p><p id="par0065" class="elsevierStylePara elsevierViewall">José Alberto García-Lozano and Diana Paola Flores-Gutierrez have nothing to disclose.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Financial support" ] 1 => array:2 [ "identificador" => "sec0010" "titulo" => "Authors’ contributions" ] 2 => array:2 [ "identificador" => "sec0015" "titulo" => "Conflicts of interest" ] 3 => array:2 [ "identificador" => "xack761229" "titulo" => "Acknowledgments" ] 4 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2023-02-23" "fechaAceptado" => "2023-05-20" "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Study conducted at Welsh Dermatology & Associates, Monterrey, NL, Mexico.</p>" ] ] "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 934 "Ancho" => 2508 "Tamanyo" => 204427 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0060" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(A) Erythrodermic psoriasis; (B) Remission after guselkumab therapy.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment response of patients with erythrodermic psoriasis after switching to Guselkumab" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C.Y. Chiang" 1 => "T.F. Tsai" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s13555-020-00480-x" "Revista" => array:6 [ "tituloSerie" => "Dermatol Ther (Heidelb)." "fecha" => "2021" "volumen" => "11" "paginaInicial" => "301" "paginaFinal" => "306" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33400156" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A case of erythrodermic psoriasis successfully treated with guselkumab" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M. Megna" 1 => "A. Ruggiero" 2 => "E. Camela" 3 => "G. Fabbrocini" 4 => "C. Marasca" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Dermatol Ther." "fecha" => "2020" "volumen" => "33" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "S. Sano" 1 => "H. Kubo" 2 => "H. Morishima" 3 => "R. Goto" 4 => "R. Zheng" 5 => "H. Nakagawa" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/1346-8138.14294" "Revista" => array:6 [ "tituloSerie" => "J Dermatol." "fecha" => "2018" "volumen" => "45" "paginaInicial" => "529" "paginaFinal" => "539" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29569397" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "HHV8-Positive castleman disease and in situ mantle cell neoplasia within dermatopathic Lymphadenitis, in longstanding psoriasis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Zanelli" 1 => "L. Stingeni" 2 => "M. Zizzo" 3 => "G. Martino" 4 => "F. Sanguedolce" 5 => "A. Marra" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Diagnostics (Basel)." "fecha" => "2021" "volumen" => "11" "paginaInicial" => "1150" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of anti-TNF and IL-inhibitors treatments in patients with psoriasis in terms of response to routine laboratory parameter dynamics" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Ataseven" 1 => "S.A. Temiz" 2 => "G. Eren" 3 => "İ Özer" 4 => "R. Dursun" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/09546634.2020.1801975" "Revista" => array:6 [ "tituloSerie" => "J Dermatolog Treat." "fecha" => "2022" "volumen" => "33" "paginaInicial" => "1091" "paginaFinal" => "1096" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32713225" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack761229" "titulo" => "Acknowledgments" "texto" => "<p id="par0070" class="elsevierStylePara elsevierViewall">No acknowledgments.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/03650596/0000009900000002/v2_202407221312/S036505962300257X/v2_202407221312/en/main.assets" "Apartado" => array:4 [ "identificador" => "96904" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letter – Therapy" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/03650596/0000009900000002/v2_202407221312/S036505962300257X/v2_202407221312/en/main.pdf?idApp=UINPBA00008Z&text.app=https://clinics.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S036505962300257X?idApp=UINPBA00008Z" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 15 | 7 | 22 |
2024 October | 114 | 67 | 181 |
2024 September | 160 | 130 | 290 |
2024 August | 173 | 171 | 344 |
2024 July | 141 | 119 | 260 |
2024 June | 130 | 106 | 236 |
2024 May | 147 | 83 | 230 |
2024 April | 240 | 116 | 356 |
2024 March | 353 | 80 | 433 |
2024 February | 89 | 84 | 173 |
2024 January | 72 | 50 | 122 |
2023 December | 80 | 74 | 154 |